NATURAL ALTERNATIVES INTERNATIONAL INC
NAIINext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for NAII. That does not mean none is planned.
Get an email about NAII's next catalysts
Track NATURAL ALTERNATIVES INTERNATIONAL (NAII) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Natural Alternatives International, Inc. (NAI) is an American company based in Carlsbad, California which manufactures nutritional supplements such as Juice Plus. NAI was founded in 1980 by Mark A. LeDoux, and had 241 employees in 2007. NAI's manufacturing facilities are located in Vista, California, Switzerland and Japan.
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
GSPE | Phase 2 | Atherosclerosis of Arteries of the Extremities, Unspecified | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in NATURAL ALTERNATIVES INTERNATIONAL INC's drug pipeline?β
CatalystAlert tracks 1 drug candidate in NATURAL ALTERNATIVES INTERNATIONAL INC's (NAII) pipeline across Phase 2. Its lead program is GSPE (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NATURAL ALTERNATIVES INTERNATIONAL INC's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track NAII biotech catalysts?β
Add NAII to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NATURAL ALTERNATIVES INTERNATIONAL INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
